News
Olon – further milestone in its plan to expand and increase production capacity
Olon, global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets,…
One year after the launch of the international network of Biocatalysis, Olon has achieved the developing a new production process through engineering target enzyme
Milan, 10th Maj 2023 – One year after the launch of the International Network for Biocatalysis, an innovative…
Generics Bulletin interviews our CEO Paolo Tubertini
With Olon investing significantly in its production capacity and technical capabilities, CEO Paolo Tubertini believes the API specialist…
Interview to Robert Poe, CEO Olon Ricerca Bioscience, published on Global Business Report
“What we are doing here is beginning the build-out of a high-potency API suite, so that we can…
OLON ANNOUNCES THAT ITS RIFAMPICIN DMF IS ELIGIBLE FOR GDUFA PRIOR ASSESSMENT AND IT MEETS THE REQUIREMENTS FOR NITROSAMINE STANDARDS
Within the framework of a consolidated and pioneering regulatory strategy, Olon announces that its Rifampicin Drug Master File…
OLON HAS BEEN SELECTED AS CHAMPION IN FIVE CATEGORIES OF 2023 CDMO LEADERSHIP AWARDS
Milan, Italy, 17 th March 23, 2023 — Olon Group, global leader in the development and production ofactive pharmaceutical ingredients…
Olon announces the completion of the investment to expand the pilot plant capacity in Rodano plant
Olon is pleased to announce the completion of the investment in its Rodano facility to expand the pilot…
OLON AND THE CHEMISTRY DEPARTMENT OF POLITECNICO UNIVERSITY LAUNCH A RESEARCH PROJECT ON POLYMORPHISM
Milan – Italy, February 20, 2023 – Olon Group and the Politecnico di Milano, Department of Chemistry, Materials…
Olon Ricerca Bioscience at Case Western Reserve University
MiKE H. O’Neill, Director, Analytical Chemistry at Olon Ricerca Bioscience LLC, gave a scientific lecture about Analytical Chemistry…
OLON, INTERNATIONAL API SUPPLIER, RELEASES THE NEW SUSTAINABILITY REPORT 2022
THE GROUP CONFIRMS THE PROGRESS OF ITS SUSTAINABILITY IN THE FOCUS AREAS OF ENVIRONMENT, SUPPLY CHAIN, PEOPLE, COMMUNITY…
Olon School, international program to develop talent
With the Olon School Project, we select young graduates, invest in their personal and professional growth within the…
Olon presents a two-year plan of investments in the Biotech Centre of Settimo Torinese
Milano, September 21 st, 2022 – As part of its strategy for global growth and the enhancement of…
A division specialising in microbial fermentation technologies
July 11th, 2022, Milan (Italy) – Olon is glad to present its new division. Olon Biotech, a division…
OLON ANNOUNCES THE CREATION OF A MAJOR CENTER OF RESEARCH AND DEVELOPMENT IN ITALY
OLON ANNOUNCES THE CREATION OF A MAJOR CENTER OF RESEARCH AND DEVELOPMENT IN ITALY, THAT WILL GIVE RISE…
Olon announces the investment in a new spray dryer in its R&D centre and it increases the capability in developing new API
To furtherly expand and increase its internal capability in developing new API, Olon announces the investment in a…
Alessandro Agosti, Senior Director of Scientific Operations at Olon Ricerca bioscience, presents a successful case study of process safety during the annual safety conference of the Purdue University
Purdue University, which includes the major Engineering School in the United States, has promoted P2SAC, one of the…
Olon Group renews its website
The communication tools of a global group, with a global footprint as Olon, require constant maintenance and updating,…
“Capacity, innovation, sustainability. Now Olon is all grown up”
This is the title of the interview to our President, Roberta Pizzocaro, published by the major Italian daily…
Olon received the 2022 Industria Felix Award
Olon received the 2022 Industria Felix Award, promoted by Cerved, National Institute for data analysis, LUISS University, officially…
Olon at the 12th Annual World ADC in London, 29th March – 1st April 2022
Olon is a global leader in the production of derivates of Anthracyclines, and the momentum and inspiration that…
CPHI WW, A SIGNIFICANT EXPANSION OF APIs PIPELINE FOR OLON GROUP
CPHI WW, A SIGNIFICANT EXPANSION OF APIs PIPELINE FOR OLON GROUP As the CPhI Worldwide 2021 takes place…
OLON GROUP ANNOUNCES THE NEXT STRATEGIC MILESTONE OF OLON RICERCA BIOSCIENCE.
OLON GROUP ANNOUNCES THE NEXT STRATEGIC MILESTONE OF OLON RICERCA BIOSCIENCE. A NEW SPACE TO PRODUCE HIGHLY POTENT…
OLON ANNOUNCES A STRATEGIC EXPANSION TO PRODUCE PROTEINS WITH AN ADVANCED AND SUSTAINABLE APPROACH
OLON ANNOUNCES A STRATEGIC EXPANSION TO PRODUCE PROTEINS WITH AN ADVANCED AND SUSTAINABLE APPROACH PAOLO TUBERTINI, CEO, COMMENTS…
OLON PRESENTS ITS NEW SUSTAINABILITY MANIFESTO
OLON PRESENTS ITS NEW SUSTAINABILITY MANIFESTO Olon is proud to present its Sustainability Manifesto 2021, published today on…
Olon atteding CPHI North America
Olon atteding CPHI North America Meet us a the forthcoming CPHI North America. We are excited to announce…
OLON aquires Ricerca Biosciences Chemical Division in Ohio (USA)
OLON aquires Ricerca Biosciences Chemical Division in Ohio (USA) (June 9, 2017)